| Literature DB >> 30678725 |
Heinrich W Nolte1, Kim Nolte2, Tamara Hew-Butler3.
Abstract
BACKGROUND: It remains unclear if ad libitum water drinking, as a hydration strategy, prevents exercise-associated hyponatremia (EAH) during prolonged exercise. The aim of this study was to determine the incidence of EAH within the broader context of fluid regulation among soldiers performing a 40-km route-march ingesting water ad libitum.Entities:
Keywords: Arginine vasopressin; Electrolyte balance; Exercise-associated hyponatremia; Fluid balance; Military; Serum sodium concentration
Mesh:
Substances:
Year: 2019 PMID: 30678725 PMCID: PMC6346586 DOI: 10.1186/s40779-019-0192-y
Source DB: PubMed Journal: Mil Med Res ISSN: 2054-9369
Body mass change, water intake and route-march time [(Mean ± SD (min – max)]
| Item | Combined ( | Serum [Na+] | |
|---|---|---|---|
| ≥ 5 mmol/L Δ ( | < 5 mmol/L Δ ( | ||
| Body Mass Pre (kg) | 73.73 ± 9.70 (60.32–98.76) | 73.96 ± 5.50 (68.82–81.36) | 73.68 ± 9.70 (60.32–98.76) |
| Body Mass Δ (%) | −4.0 ± 1.4 (− 0.6 – − 7.2)** | −3.0 ± 1.7 (− 0.6 - -4.5)* | −4.4 ± 1.2 (− 2.7 - -7.2) |
| Total Water Intake (L) | 6.7 ± 2.3 (2.9–11.8) | 7.4 ± 1.7 (5.9–9.8) | 6.3 ± 2.3 (2.9–11.8) |
| Hourly Water Intake (ml/h) | 736 ± 259 (290–1245) | 853 ± 198 (684–1166) | 691 ± 270 (290–1245) |
| Route-March Time (hh:mm) | 09:11 ± 00:42 (08:19–10:25) | 8.72 ± 0.29 (8.19–9.17) | 9.26 ± 0.69 (8.40–10.25) |
P < 0.05 between plasma [Na+] ≥ 5 mmol/L Δ vs. < 5 mmol/L Δ; P < 0.05 between pre- and post-route-march values
Serum (S), plasma (P) and urine (U) variables measured pre- and post-march [(Mean ± SD (min – max)]
| Item | Combined ( | Serum [Na+] | |
|---|---|---|---|
| ≥ 5 mmol/L Δ ( | < 5 mmol/L Δ ( | ||
| S [Na+] Pre (mmol/L) | 141 ± 1 (140–143) | 141 ± 1 (140–143) | 141 ± 1 (140–143) |
| S [Na+] Post (mmol/L) | 139 ± 2 (134–143)@ | 135 ± 1 (134–138)*** | 140 ± 2 (138–143) |
| S [Cl−] Pre (mmol/L) | 105 ± 2 (100–109) | 104 ± 2 (101–107) | 105 ± 2 (100–109) |
| S [Cl−] Post (mmol/L) | 105 ± 2 (100–110) | 102 ± 2 (100–104)** | 106 ± 2 (102–110) |
| P Osm Pre (mOsmol/kg H2O) | 303 ± 8 (294–320) | 300 ± 5 (294–307) | 303 ± 8 (294–320) |
| P Osm Post (mOsmol/kg H2O) | 298 ± 8 (285–323)@ | 297 ± 11 (285–314) | 299 ± 8 (289–323) |
| P [AVP] Pre (pg/ml) | 2.2 ± 1.5 (0.5–7.8) | 1.4 ± 0.6 (0.5–2.2) | 2.4 ± 1.6 (0.5–7.8) |
| P [AVP] Post (pg/ml) | 11.2 ± 6.4 (1.8–32.8)@ | 11.4 ± 3.5 (6.8–14.3) | 11.5 ± 7.1 (3–32.8) |
| S [BUN] Pre (mg/dl) | 22.4 ± 4.4 (12.6–32.7) | 21.6 ± 3.9 (16.2–26.3) | 22.9 ± 3.6 (12.6–32.7) |
| S [BUN] Post (mg/dl) | 28.9 ± 4.0 (21.8–35.0)@ | 30.9 ± 5.5 (21.8–35.0) | 28.5 ± 5.5 (22.1–34.7) |
| S [Glucose] Pre (mmol/L) | 4.9 ± 0.7 (3.5–6.1) | 5.4 ± 0.5 (4.8–6.1) | 4.8 ± 0.8 (3.5–6.1) |
| S [Glucose] Post (mmol/L) | 4.8 ± 1.0 (3.1–7.7) | 4.0 ± 0.5 (3.1–4.5)* | 5.1 ± 1.1 (4.0–7.7) |
| S [CK] Pre (U/L) | 1422 ± 830 (426–3192) | 1148 ± 521 (530–1652) | 1346 ± 760 (426–3192) |
| S [CK] Post (U/L) | 3893 ± 6359) (933–5121) | 2301 ± 543 (1604–2860) | 2696 ± 1135 (923–5121) |
| S [Creatinine] Post (ʮmol/L) | 111 ± 18 (73–155) | 107 ± 12 (93–125) | 114 ± 18 (73–155) |
| S [Creatinine] Post (ʮmol/L) | 100 ± 15) (63–137) | 105 ± 14 (83–125) | 98 ± 14 (63–137) |
| P volume Δ (%) | −11.9 ± 25.1 (− 27.3–27.5) | −4.7 ± 32.9 (− 19.7–24.8) | −13.7 ± 23.4 (− 27.3–27.5) |
| U [Na+] Pre (mmol/L) | 168 ± 37 (61–230) | 141 ± 58 (61–221) | 175 ± 31 (100–230) |
| U [Na+] Post (mmol/L) | 142 ± 54 (50–257)@ | 95 ± 32 (50–141)* | 159 ± 53 (56–257) |
| U Osm Pre (mOsmol/kg H2O) | 1025 ± 156 (747–1362) | 1002 ± 185 (747–1231) | 1045 ± 139 (795–1362) |
| U Osm Post (mOsmol/kg H2O) | 1097 ± 136 (788–1388)@ | 1046 ± 198 (788–1313) | 1114 ± 125 (845–1388) |
*P < 0.05; **P < 0.01; ***P < 0.001; between plasma [Na+] ≥ 5 mmol/L Δ vs. < 5 mmol/L Δ; @P < 0.05 between pre-march vs. post-march
Na+ Sodium, Cl− Chloride, Osm Osmolality, AVP Arginine vasopressin, BUN Blood urea nitrogen, CK Creatine kinase